Advertisement

Critical Care

, 23:115 | Cite as

Lack of relationship between fasting plasma citrulline and glucose absorption: do not underestimate the role of the failing kidney!

  • Patrick M. HonoreEmail author
  • David De Bels
  • Andrea Gallerani
  • Rachid Attou
  • Willem Boer
Open Access
Letter

Abbreviations

AKI

Acute kidney injury

ARDS

Acute respiratory distress syndrome

CKD

Chronic kidney disease

CRRT

Continuous renal replacement therapy

IHD

Intermittent hemodialysis

RRT

Renal replacement therapy

Poole et al. published in a relatively recent paper in Critical Care concluding that, while both plasma citrulline concentrations and glucose absorption were reduced in critical illness, fasting plasma citrulline concentrations were not predictive of subsequent glucose absorption and therefore do not appear to be a marker of small intestinal absorptive function [1]. It is argued that the degree of reduction in citrulline concentration may be curtailed by renal dysfunction. Cynober [2] demonstrated that citrulline is mainly metabolized by the kidney, where it is converted into arginine by cells of the proximal tubules [2]. Approximately 83% of the citrulline released by the gut is metabolized within the kidney [2]. Synthesized arginine is released into the general blood circulation. In adults, the citrulline converted by the kidney is enough to provide the body’s full arginine requirements. Arginine synthesized from citrulline represents 60% of the de novo arginine synthesis in the organism [2]. In the Poole study, four patients out of 20 (20%) were in acute kidney injury (AKI) with a creatinine level > 100 μmol/L. These were therefore unable to metabolize a large part of the citrulline released by the gut, hindering interpretation of mean citrulline levels as blunting of the relationship between fasting plasma citrulline concentrations and glucose adsorption is likely. Ware et al. [3] described low levels of citrulline in severe sepsis and a concomitant association with acute respiratory distress syndrome (ARDS). Cynober commented on the Ware publication [4] that, despite the fact that 41% of patients were in AKI, no difference was demonstrated between patients with or without AKI, attributing the absence of expected increase in citrulline levels in AKI to an unknown covariable (for example, gut failure) decreasing citrulline levels [4]. In one study, citrulline (MW = 15 kDa) was reduced by 55% in a session of 90 min of intermittent hemodialysis (IHD) [5]. Continuous renal replacement therapy (CRRT) will likely extract citrulline more efficiently. Of the 41% who were in AKI in the Ware study, half could be expected to be on some forms of renal replacement therapy (RRT), explaining the low citrulline levels in the AKI group. We conclude that patients with AKI or chronic kidney disease (CKD), causing citrulline increase, and patients on RRT, causing a decrease, should be excluded from studies.

Notes

Acknowledgements

None.

Funding

None.

Availability of data and materials

Not applicable.

Authors’ contributions

PMH and WB designed the paper. All authors participated in drafting and reviewing. All authors read and approved the final version of the manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.
    Poole A, Deane A, Summers M, Fletcher J, Chapman M. The relationship between fasting plasma citrulline concentration and small intestinal function in the critically ill. Crit Care. 2015;19:16.  https://doi.org/10.1186/s13054-014-0725-4.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Bénazeth S, et al. Almost all about citrulline in mammals. Amino Acids. 2005;29(3):177–205 Epub 2005 Aug 8. Review.CrossRefGoogle Scholar
  3. 3.
    Ware LB, Magarik JA, Wickersham N, Cunningham G, Rice TW, Christman BW, et al. Low plasma citrulline levels are associated with acute respiratory distress syndrome in patients with severe sepsis. Crit Care. 2013;17(1):R10.  https://doi.org/10.1186/cc11934.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Cynober L. Citrulline: just a biomarker or a conditionally essential amino acid and a pharmaconutrient in critically ill patients? Crit Care. 2013;17(2):122.  https://doi.org/10.1186/cc12534.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    McBryde KD, Kudelka TL, Kershaw DB, Brophy PD, Gardner JJ, Smoyer WE. Clearance of amino acids by hemodialysis in argininosuccinate synthetase deficiency. J Pediatr. 2004;144(4):536–40.CrossRefGoogle Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Patrick M. Honore
    • 1
    Email author
  • David De Bels
    • 1
  • Andrea Gallerani
    • 1
  • Rachid Attou
    • 1
  • Willem Boer
    • 2
  1. 1.ICU DepartmentCentre Hospitalier Universitaire Brugmann-Brugmann University HospitalBrusselsBelgium
  2. 2.Dept. of Anesthesiology, Intensive Care Medicine, Emergency Medicine & Pain MedicineZiekenhuis Oost-LimburgGenkBelgium

Personalised recommendations